Frank A. Holler, Director at Xenon Pharmaceuticals Inc. (XENE), sold 23,876 shares at $7.65 ($183K) on 2016-08-19, disclosed to the SEC on 2016-08-23.
Open-market sale of $183k XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.65 | 11,938 | $91K | 50.0% |
| 2 | $7.65 | 11,938 | $91K | 50.0% |
| Total | $7.65 avg | 23,876 | $183K | 100% |
| Filing → |
| XENE | SELL | 2019-09-18 | $88K | — | Filing → |
| XENE | SELL | 2016-12-19 | $236K | — | Filing → |
| XENE | SELL | 2016-08-18 | $274K | — | Filing → |